Cite
Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome.
MLA
Wendel, Eva-Maria, et al. “Serum Neurofilament Light-Chain Levels in Children with Monophasic Myelin Oligodendrocyte Glycoprotein-Associated Disease, Multiple Sclerosis, and Other Acquired Demyelinating Syndrome.” Multiple Sclerosis Journal, vol. 28, no. 10, Sept. 2022, pp. 1553–61. EBSCOhost, https://doi.org/10.1177/13524585221081090.
APA
Wendel, E.-M., Bertolini, A., Kousoulos, L., Rauchenzauner, M., Schanda, K., Wegener-Panzer, A., Baumann, M., Reindl, M., Otto, M., & Rostásy, K. (2022). Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome. Multiple Sclerosis Journal, 28(10), 1553–1561. https://doi.org/10.1177/13524585221081090
Chicago
Wendel, Eva-Maria, Annikki Bertolini, Lampros Kousoulos, Markus Rauchenzauner, Kathrin Schanda, Andreas Wegener-Panzer, Matthias Baumann, Markus Reindl, Markus Otto, and Kevin Rostásy. 2022. “Serum Neurofilament Light-Chain Levels in Children with Monophasic Myelin Oligodendrocyte Glycoprotein-Associated Disease, Multiple Sclerosis, and Other Acquired Demyelinating Syndrome.” Multiple Sclerosis Journal 28 (10): 1553–61. doi:10.1177/13524585221081090.